BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ayieko J, Abuogi L, Simchowitz B, Bukusi EA, Smith AH, Reingold A. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta-analysis. BMC Infect Dis. 2014;14:91. [PMID: 24555539 DOI: 10.1186/1471-2334-14-91] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Santos JM, Fachi MM, Beraldi-Magalhães F, Böger B, Junker AM, Domingos EL, Imazu P, Fernandez-Llimos F, Tonin FS, Pontarolo R. Systematic review with network meta-analysis on the treatments for latent tuberculosis infection in children and adolescents. J Infect Chemother 2022:S1341-321X(22)00249-5. [PMID: 36075488 DOI: 10.1016/j.jiac.2022.08.023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Wu J, Zhu L, Yu J, Liu Q, Ding X, Lu P, Wu Y, Sun J, Martinez L, Lu W, Wang J. A university-clustered tuberculosis outbreak during the COVID-19 pandemic in eastern China. Front Public Health 2022;10:978159. [DOI: 10.3389/fpubh.2022.978159] [Reference Citation Analysis]
3 Onyango DO, van der Sande MAB, Yuen CM, Mecha J, Matemo D, Oele E, Kinuthia J, John-Stewart G, LaCourse SM. Drop-offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015-2019. J Int AIDS Soc 2022;25:e25939. [PMID: 35927793 DOI: 10.1002/jia2.25939] [Reference Citation Analysis]
4 Sabella-jiménez V, Hoyos Mendez Y, Benjumea-bedoya D, Estupiñán-bohorquez AF, Acosta-reyes J, Florez ID. Effectiveness and safety of available preventive tuberculosis treatment regimens for children and adolescents: protocol for a systematic review and network meta-analysis. bmjpo 2022;6:e001551. [DOI: 10.1136/bmjpo-2022-001551] [Reference Citation Analysis]
5 Maphalle LNF, Michniak-kohn BB, Ogunrombi MO, Adeleke OA. Pediatric Tuberculosis Management: A Global Challenge or Breakthrough? Children 2022;9:1120. [DOI: 10.3390/children9081120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lacourse SM, Onyango D. Promoting tuberculosis preventive therapy in HIV. The Lancet HIV 2022. [DOI: 10.1016/s2352-3018(22)00197-7] [Reference Citation Analysis]
7 du Preez K, Jenkins HE, Donald PR, Solomons RS, Graham SM, Schaaf HS, Starke JR, Hesseling AC, Seddon JA. Tuberculous Meningitis in Children: A Forgotten Public Health Emergency. Front Neurol 2022;13:751133. [DOI: 10.3389/fneur.2022.751133] [Reference Citation Analysis]
8 Jaganath D, Beaudry J, Salazar-austin N. Tuberculosis in Children. Infectious Disease Clinics of North America 2022;36:49-71. [DOI: 10.1016/j.idc.2021.11.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Arega B, Negesso A, Taye B, Weldeyohhans G, Bewket B, Negussie T, Teshome A, Endazenew G. Impact of COVID-19 pandemic on TB prevention and care in Addis Ababa, Ethiopia: a retrospective database study. BMJ Open 2022;12:e053290. [PMID: 35135769 DOI: 10.1136/bmjopen-2021-053290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Russom M, Woldu HG, Berhane A, Jeannetot DYB, Stricker BH, Verhamme K. Effectiveness of a 6-Month Isoniazid on Prevention of Incident Tuberculosis Among People Living with HIV in Eritrea: A Retrospective Cohort Study. Infect Dis Ther. [DOI: 10.1007/s40121-022-00589-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Chakroun M, Kooli I, Marrakchi W, Brahim HB, Aouam A, Toumi A. Tuberculosis and Human Immunodeficiency Virus Co-infection. Imaging of Tuberculosis 2022. [DOI: 10.1007/978-3-031-07040-2_14] [Reference Citation Analysis]
12 Sharma N, Basu S, Khanna A, Sharma P, Chopra KK, Chandra S. Adherence to Isoniazid Preventive Therapy among children living with tuberculosis patients in Delhi, India: An exploratory prospective study. Indian Journal of Tuberculosis 2022;69:100-3. [DOI: 10.1016/j.ijtb.2021.03.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Thean >SY, Chan >T, Yeoh >S, Ng >C. stability-study-of-an-extemporaneous-isoniazid-oral-suspension-prepared-using-commercially-available-tablets-with-x-temp-oral-suspension-system. Mal J Pharm 2021;7:77-84. [DOI: 10.52494/lmnn7856] [Reference Citation Analysis]
14 Tolofoudie M, Somboro A, Diarra B, Sarro YS, Drame HB, Togo ACG, Sanogo M, Dembele A, Togun T, Nkereuwem E, Baya B, Konate B, Egere U, Traore M, Maiga M, Saliba-Shaw K, Kampmann B, Diallo S, Doumbia S, Sylla M. Isoniazid preventive therapy in child household contacts of adults with active TB in Bamako, Mali. Public Health Action 2021;11:191-5. [PMID: 34956847 DOI: 10.5588/pha.21.0061] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hirsch-Moverman Y, Strauss M, George G, Mutiti A, Mafukidze A, Shongwe S, Dube GS, El Sadr WM, Mantell JE, Howard AA. Paediatric tuberculosis preventive treatment preferences among HIV-positive children, caregivers and healthcare providers in Eswatini: a discrete choice experiment. BMJ Open 2021;11:e048443. [PMID: 34686549 DOI: 10.1136/bmjopen-2020-048443] [Reference Citation Analysis]
16 Van Ginderdeuren E, Bassett J, Hanrahan CF, Mutunga L, Van Rie A. Gaps in the tuberculosis preventive therapy care cascade in children in contact with TB. Paediatr Int Child Health 2021;:1-10. [PMID: 34533111 DOI: 10.1080/20469047.2021.1971360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Moore DP, Baillie VL, Mudau A, Wadula J, Adams T, Mangera S, Verwey C, Prosperi C, Higdon MM, Haddix M, Hammitt LL, Feikin DR, O'Brien KL, Deloria Knoll M, Murdoch DR, Simões EAF, Madhi SA. The Etiology of Pneumonia in HIV-uninfected South African Children: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study. Pediatr Infect Dis J 2021;40:S59-68. [PMID: 34448745 DOI: 10.1097/INF.0000000000002650] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
18 LaCourse SM, Leon D, Panpradist N, Richardson BA, Maleche-Obimbo E, Mecha J, Matemo D, Escudero JN, Kinuthia J, Lutz B, John-Stewart G. Urine Biomarker Assessment of Infant Adherence to Isoniazid Prophylaxis. Pediatr Infect Dis J 2021;40:e43-5. [PMID: 33055504 DOI: 10.1097/INF.0000000000002936] [Reference Citation Analysis]
19 LaCourse SM, Richardson BA, Kinuthia J, Warr AJ, Maleche-Obimbo E, Matemo D, Cranmer LM, Mecha J, Escudero JN, Hawn TR, John-Stewart G. A Randomized Controlled Trial of Isoniazid to Prevent Mycobacterium tuberculosis Infection in Kenyan Human Immunodeficiency Virus-Exposed Uninfected Infants. Clin Infect Dis 2021;73:e337-44. [PMID: 32564076 DOI: 10.1093/cid/ciaa827] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
20 Ronge L, Sloot R, Du Preez K, Kay AW, Kirchner HL, Grewal HMS, Mandalakas AM, Hesseling AC. The Magnitude of Interferon Gamma Release Assay Responses in Children With Household Tuberculosis Contact Is Associated With Tuberculosis Exposure and Disease Status. Pediatr Infect Dis J 2021;40:763-70. [PMID: 34050092 DOI: 10.1097/INF.0000000000003196] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 van de Water BJ, Meyer TN, Wilson M, Young C, Gaunt B, le Roux KW. TB prevention cascade at a district hospital in rural Eastern Cape, South Africa. Public Health Action 2021;11:97-100. [PMID: 34159070 DOI: 10.5588/pha.20.0055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Nordholm AC, Lillebaek T. It is time to optimise the management of latent tuberculosis infection in children. Eur Respir J 2021;57:2004438. [PMID: 33888534 DOI: 10.1183/13993003.04438-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Mandalakas AM, Hesseling AC, Kay A, Du Preez K, Martinez L, Ronge L, DiNardo A, Lange C, Kirchner HL. Tuberculosis prevention in children: a prospective community-based study in South Africa. Eur Respir J 2021;57:2003028. [PMID: 33122339 DOI: 10.1183/13993003.03028-2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Gaffney H, Ttofi MM, Farrington DP. Effectiveness of school‐based programs to reduce bullying perpetration and victimization: An updated systematic review and meta‐analysis. Campbell Systematic Reviews 2021;17. [DOI: 10.1002/cl2.1143] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
25 Salazar-Austin N, Milovanovic M, West NS, Tladi M, Barnes GL, Variava E, Martinson N, Chaisson RE, Kerrigan D. Post-trial perceptions of a symptom-based TB screening intervention in South Africa: implementation insights and future directions for TB preventive healthcare services. BMC Nurs 2021;20:29. [PMID: 33557831 DOI: 10.1186/s12912-021-00544-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 du Preez K, Osman M, Seddon JA, Naidoo P, Schaaf HS, Munch Z, Dunbar R, Mvusi L, Dlamini SS, Hesseling AC. The impact of the evolving HIV response on the epidemiology of tuberculosis in South African children and adolescents. Clin Infect Dis 2021:ciab095. [PMID: 33532853 DOI: 10.1093/cid/ciab095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Dorjee K, Topgyal S, Tsewang T, Tsundue T, Namdon T, Bonomo E, Kensler C, Lhadon D, Choetso T, Nangsel T, Dolkar T, Tsekyi T, Dorjee C, Phunkyi D, Sadutshang TD, Paster Z, Chaisson RE. Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: An impact assessment. PLoS Med 2021;18:e1003502. [PMID: 33465063 DOI: 10.1371/journal.pmed.1003502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Salazar-Austin N, Cohn S, Barnes GL, Tladi M, Motlhaoleng K, Swanepoel C, Motala Z, Variava E, Martinson N, Chaisson RE. Improving Tuberculosis Preventive Therapy Uptake: A Cluster-randomized Trial of Symptom-based Versus Tuberculin Skin Test-based Screening of Household Tuberculosis Contacts Less Than 5 Years of Age. Clin Infect Dis 2020;70:1725-32. [PMID: 31127284 DOI: 10.1093/cid/ciz436] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
29 Kay AW, Thivalapill N, Skinner D, Dube GS, Dlamini N, Mzileni B, Fuentes P, Ustero P, Adams LV, Mandalakas AM. Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV. PLoS One 2020;15:e0243713. [PMID: 33332462 DOI: 10.1371/journal.pone.0243713] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
30 Gatchalian SR, Agathis NT, Castillo-Carandang NT, Gunter SM, Murray KO, Mandalakas AM. Design and Evaluation of Risk Assessment Tools to Identify Pediatric Tuberculosis Infection in Bohol, the Philippines, a Low-HIV- and High-TB-Burden Setting. Am J Trop Med Hyg 2020;103:1818-26. [PMID: 32975174 DOI: 10.4269/ajtmh.20-0244] [Reference Citation Analysis]
31 Seid G, Tsedalu T, Ayele M. Adherence to Isoniazid Preventive Therapy among Under-Five Children in Contact with Adult Bacteriologically Confirmed Pulmonary Tuberculosis Patients: A Mixed-Method Study. Int J Microbiol 2020;2020:8834806. [PMID: 33061981 DOI: 10.1155/2020/8834806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Dorjee K, Topgyal S, Dorjee C, Tsundue T, Namdol T, Tsewang T, Nangsel T, Lhadon D, Choetso T, Dawa T, Phentok T, DeLuca AN, Tsering L, Phunkyi D, Sadutshang TD, J Bonomo E, Paster Z, Chaisson RE. High Prevalence of Active and Latent Tuberculosis in Children and Adolescents in Tibetan Schools in India: The Zero TB Kids Initiative in Tibetan Refugee Children. Clin Infect Dis 2019;69:760-8. [PMID: 30462191 DOI: 10.1093/cid/ciy987] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
33 Fentahun N, Wasihun Y, Mamo A, Gebretsadik LA. Contact Screening and Isoniazid Preventive Therapy Initiation for Under-Five Children among Pulmonary Tuberculosis-Positive Patients in Bahir Dar Special Zone, Northwest Ethiopia: A Cross-Sectional Study. Tuberc Res Treat 2020;2020:6734675. [PMID: 32566291 DOI: 10.1155/2020/6734675] [Reference Citation Analysis]
34 Hirsch-Moverman Y, Mantell JE, Lebelo L, Howard AA, Hesseling AC, Nachman S, Frederix K, Maama LB, El-Sadr WM. Provider attitudes about childhood tuberculosis prevention in Lesotho: a qualitative study. BMC Health Serv Res 2020;20:461. [PMID: 32450858 DOI: 10.1186/s12913-020-05324-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Meremikwu M, Zumla A. Isoniazid preventive therapy for children in sub-Saharan Africa. Lancet Respir Med 2019;7:197-9. [PMID: 30823970 DOI: 10.1016/S2213-2600(19)30037-2] [Reference Citation Analysis]
36 Martinez L, Cords O, Horsburgh CR, Andrews JR; Pediatric TB Contact Studies Consortium. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. Lancet 2020;395:973-84. [PMID: 32199484 DOI: 10.1016/S0140-6736(20)30166-5] [Cited by in Crossref: 87] [Cited by in F6Publishing: 88] [Article Influence: 43.5] [Reference Citation Analysis]
37 Aleinikova D, Pole I, Kimsis J, Skangale A, Bobrikova O, Kazelnika R, Jansone I, Norvaisa I, Ozere I, Ranka R. Application of whole-genome sequencing in a case study of renal tuberculosis in a child. BMC Infect Dis 2020;20:105. [PMID: 32024474 DOI: 10.1186/s12879-020-4832-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Salazar-Austin N, Dowdy DW, Chaisson RE, Golub JE. Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration. Am J Epidemiol 2019;188:2078-85. [PMID: 31364692 DOI: 10.1093/aje/kwz172] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
39 Charan J, Goyal JP, Reljic T, Emmanuel P, Patel A, Kumar A. Isoniazid for the Prevention of Tuberculosis in HIV-Infected Children: A Systematic Review and Meta-Analysis. Pediatr Infect Dis J 2018;37:773-80. [PMID: 29280783 DOI: 10.1097/INF.0000000000001879] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
40 Tiruneh G, Getahun A, Adeba E. Assessing the Impact of Isoniazid Preventive Therapy (IPT) on Tuberculosis Incidence and Predictors of Tuberculosis among Adult Patients Enrolled on ART in Nekemte Town, Western Ethiopia: A Retrospective Cohort Study. Interdiscip Perspect Infect Dis 2019;2019:1413427. [PMID: 31186628 DOI: 10.1155/2019/1413427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
41 Birungi FM, Graham SM, Uwimana J, Musabimana A, van Wyk B. Adherence to isoniazid preventive therapy among child contacts in Rwanda: A mixed-methods study. PLoS One 2019;14:e0211934. [PMID: 30742660 DOI: 10.1371/journal.pone.0211934] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
42 Goenka A, Jeena PM, Mlisana K, Solomon T, Spicer K, Stephenson R, Verma A, Dhada B, Griffiths MJ. Rapid Accurate Identification of Tuberculous Meningitis Among South African Children Using a Novel Clinical Decision Tool. Pediatr Infect Dis J 2018;37:229-34. [PMID: 28777205 DOI: 10.1097/INF.0000000000001726] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
43 Grace SG. Barriers to the implementation of isoniazid preventive therapy for tuberculosis in children in endemic settings: A review. J Paediatr Child Health 2019;55:278-84. [PMID: 30604557 DOI: 10.1111/jpc.14359] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
44 Dinardo A, Mandalakas AM. Potential Immunology, Transcriptomics and Epigenomic Prediction Tools of the Future to Improve tuberculosis Control. Tuberculosis Host-Pathogen Interactions 2019. [DOI: 10.1007/978-3-030-25381-3_10] [Reference Citation Analysis]
45 Arscott-mills T, Marais B, Steenhoff A. HIV and Tuberculosis in Children. HIV and Tuberculosis 2019. [DOI: 10.1007/978-3-030-29108-2_12] [Reference Citation Analysis]
46 Endalamaw A, Engeda EH, Tezera N. Incidence of tuberculosis in children on antiretroviral therapy: a retrospective cohort study. BMC Res Notes 2018;11:745. [PMID: 30342550 DOI: 10.1186/s13104-018-3846-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
47 Basu Roy R, Whittaker E, Seddon JA, Kampmann B. Tuberculosis susceptibility and protection in children. Lancet Infect Dis 2019;19:e96-e108. [PMID: 30322790 DOI: 10.1016/S1473-3099(18)30157-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 11.8] [Reference Citation Analysis]
48 Dodd PJ, Yuen CM, Becerra MC, Revill P, Jenkins HE, Seddon JA. Potential effect of household contact management on childhood tuberculosis: a mathematical modelling study. Lancet Glob Health 2018;6:e1329-38. [PMID: 30266570 DOI: 10.1016/S2214-109X(18)30401-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 10.3] [Reference Citation Analysis]
49 Szkwarko D, Owiti P, Buziba N, Bigelow C, Eaton CB, Carter EJ. Implementation of an active, clinic-based child tuberculosis contact management strategy in western Kenya. Public Health Action 2018;8:91-4. [PMID: 29946526 DOI: 10.5588/pha.17.0119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
50 DeLuca A, Dhumal G, Paradkar M, Suryavanshi N, Mave V, Kohli R, Shivakumar SVBY, Hulyolkar V, Gaikwad A, Nangude A, Pardeshi G, Kadam D, Gupta A. Addressing knowledge gaps and prevention for tuberculosis-infected Indian adults: a vital part of elimination. BMC Infect Dis 2018;18:202. [PMID: 29720095 DOI: 10.1186/s12879-018-3116-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
51 Bunyasi EW, Luabeya AKK, Tameris M, Geldenhuys H, Mulenga H, Landry BS, Scriba TJ, Schmidt BM, Hanekom WA, Mahomed H, McShane H, Hatherill M. Impact of isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination. Int J Tuberc Lung Dis 2017;21:778-83. [PMID: 28633702 DOI: 10.5588/ijtld.16.0709] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
52 Sekadde MP, Kay AW. Tuberculosis Prevention: an Under Prioritized yet Critical Intervention to Reduce Child Tuberculosis Morbidity and Mortality. Curr Trop Med Rep 2018;5:51-8. [DOI: 10.1007/s40475-018-0139-5] [Reference Citation Analysis]
53 Dodd PJ, Yuen CM, Sismanidis C, Seddon JA, Jenkins HE. The global burden of tuberculosis mortality in children: a mathematical modelling study. Lancet Glob Health 2017;5:e898-906. [PMID: 28807188 DOI: 10.1016/S2214-109X(17)30289-9] [Cited by in Crossref: 177] [Cited by in F6Publishing: 188] [Article Influence: 44.3] [Reference Citation Analysis]
54 Singh AR, Kharate A, Bhat P, Kokane AM, Bali S, Sahu S, Verma M, Nagar M, Kumar AM. Isoniazid Preventive Therapy among Children Living with Tuberculosis Patients: Is It Working? A Mixed-Method Study from Bhopal, India. J Trop Pediatr 2017;63:274-85. [PMID: 28082666 DOI: 10.1093/tropej/fmw086] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
55 Mwasubila YK, Sabi I, Kabyemera R, Ntinginya NE, Sauve R, Kidenya B. Tuberculosis Contact Screening and Isoniazid Preventive Therapy Among Children Under 5 in the Mbeya and Songwe Regions, Tanzania. East Afr Health Res J 2018;2:29-32. [PMID: 34308172 DOI: 10.24248/EAHRJ-D-17-00186] [Reference Citation Analysis]
56 Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P. Tuberculosis. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Disease Control Priorities, Third Edition (Volume 6): Major Infectious Diseases. The World Bank; 2017. pp. 233-313. [DOI: 10.1596/978-1-4648-0524-0_ch11] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 4.6] [Reference Citation Analysis]
57 Hirsch-Moverman Y, Howard AA, Frederix K, Lebelo L, Hesseling A, Nachman S, Mantell JE, Lekhela T, Maama LB, El-Sadr WM. The PREVENT study to evaluate the effectiveness and acceptability of a community-based intervention to prevent childhood tuberculosis in Lesotho: study protocol for a cluster randomized controlled trial. Trials 2017;18:552. [PMID: 29157275 DOI: 10.1186/s13063-017-2184-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
58 Goyal V, Kadam V, Narang P, Singh V. Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis. BMC Public Health 2017;17:817. [PMID: 29041901 DOI: 10.1186/s12889-017-4779-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
59 Okwara FN, Oyore JP, Were FN, Gwer S. Correlates of isoniazid preventive therapy failure in child household contacts with infectious tuberculosis in high burden settings in Nairobi, Kenya - a cohort study. BMC Infect Dis 2017;17:623. [PMID: 28915796 DOI: 10.1186/s12879-017-2719-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
60 Szkwarko D, Hirsch-Moverman Y, Du Plessis L, Du Preez K, Carr C, Mandalakas AM. Child contact management in high tuberculosis burden countries: A mixed-methods systematic review. PLoS One 2017;12:e0182185. [PMID: 28763500 DOI: 10.1371/journal.pone.0182185] [Cited by in Crossref: 58] [Cited by in F6Publishing: 67] [Article Influence: 11.6] [Reference Citation Analysis]
61 Mohammadi T, Bansback N, Marra F, Khakban A, Campbell JR, Fitzgerald JM, Lynd LD, Marra CA. Testing the External Validity of a Discrete Choice Experiment Method: An Application to Latent Tuberculosis Infection Treatment. Value in Health 2017;20:969-75. [DOI: 10.1016/j.jval.2017.04.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
62 Jenkins HE. Global Burden of Childhood Tuberculosis. Pneumonia (Nathan) 2016;8:24. [PMID: 28003956 DOI: 10.1186/s41479-016-0018-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
63 Koné Z, Coulibaly G, Daix AT, Bakayoko AS, Samaké K, Kouassi DP, Domoua KM. [Current situation of primary prophylaxis with isoniazid (INH) in children who are contacts of patients with bacillary pulmonary tuberculosis in Abidjan (Cote d'Ivoire)]. Rev Pneumol Clin 2016;72:340-5. [PMID: 27776945 DOI: 10.1016/j.pneumo.2016.08.003] [Reference Citation Analysis]
64 Luabeya KK, Tameris MD, Geldenhuys HD, Mulenga H, Van Schalkwyk A, Hughes EJ, Toefey A, Scriba TJ, Hussey G, Mahomed H, McShane H, Landry B, Hanekom WA, Hatherill M. Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children. Pediatr Infect Dis J 2015;34:1218-22. [PMID: 26252568 DOI: 10.1097/INF.0000000000000874] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
65 Trauer JM, Moyo N, Tay EL, Dale K, Ragonnet R, McBryde ES, Denholm JT. Risk of Active Tuberculosis in the Five Years Following Infection . . . 15%? Chest 2016;149:516-25. [PMID: 26867835 DOI: 10.1016/j.chest.2015.11.017] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 10.3] [Reference Citation Analysis]
66 Tadesse Y, Gebre N, Daba S, Gashu Z, Habte D, Hiruy N, Negash S, Melkieneh K, Jerene D, K Haile Y, Kassie Y, Melese M, G Suarez P. Uptake of Isoniazid Preventive Therapy among Under-Five Children: TB Contact Investigation as an Entry Point. PLoS One 2016;11:e0155525. [PMID: 27196627 DOI: 10.1371/journal.pone.0155525] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
67 Costenaro P, Massavon W, Lundin R, Nabachwa SM, Fregonese F, Morelli E, Alowo A, Nannyonga Musoke M, Namisi CP, Kizito S, Bilardi D, Mazza A, Cotton MF, Giaquinto C, Penazzato M. Implementation and Operational Research: Implementation of the WHO 2011 Recommendations for Isoniazid Preventive Therapy (IPT) in Children Living With HIV/AIDS: A Ugandan Experience. J Acquir Immune Defic Syndr 2016;71:e1-8. [PMID: 26761275 DOI: 10.1097/QAI.0000000000000806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
68 Cruz AT, Starke JR. Managing tuberculosis infection in children in the USA: an update. Future Microbiol 2016;11:669-84. [PMID: 27164182 DOI: 10.2217/fmb-2016-0027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
69 Alemu YM, Andargie G, Gebeye E. High Incidence of Tuberculosis in the Absence of Isoniazid and Cotrimoxazole Preventive Therapy in Children Living with HIV in Northern Ethiopia: A Retrospective Follow-Up Study. PLoS One 2016;11:e0152941. [PMID: 27070435 DOI: 10.1371/journal.pone.0152941] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
70 Gebreegziabher SB, Yimer SA, Bjune GA. Qualitative Assessment of Challenges in Tuberculosis Control in West Gojjam Zone, Northwest Ethiopia: Health Workers' and Tuberculosis Control Program Coordinators' Perspectives. Tuberc Res Treat 2016;2016:2036234. [PMID: 27066271 DOI: 10.1155/2016/2036234] [Cited by in Crossref: 8] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
71 Pathak V, Harrington Z, Dobler CC. Attitudes towards preventive tuberculosis treatment among hospital staff. PeerJ 2016;4:e1738. [PMID: 26966667 DOI: 10.7717/peerj.1738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
72 Baytunca MB, Erermis S, Bildik T, Kayahan B. Isoniazid-Induced Psychosis with Obsessive-Compulsive Symptoms (Schizo-Obsessive Disorder) in a Female Child. Journal of Child and Adolescent Psychopharmacology 2015;25:819-20. [DOI: 10.1089/cap.2014.0065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
73 Rangaka MX, Cavalcante SC, Marais BJ, Thim S, Martinson NA, Swaminathan S, Chaisson RE. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet 2015;386:2344-53. [PMID: 26515679 DOI: 10.1016/S0140-6736(15)00323-2] [Cited by in Crossref: 117] [Cited by in F6Publishing: 102] [Article Influence: 16.7] [Reference Citation Analysis]
74 Mandalakas AM, Kirchner HL, Walzl G, Gie RP, Schaaf HS, Cotton MF, Grewal HM, Hesseling AC. Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting. Am J Respir Crit Care Med 2015;191:820-30. [PMID: 25622087 DOI: 10.1164/rccm.201406-1165OC] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
75 Short Course Prevention of TB in Children and Adolescents. AAP Grand Rounds 2015;33:62-62. [DOI: 10.1542/gr.33-6-62] [Reference Citation Analysis]
76 Akolo C, Bada F, Okpokoro E, Nwanne O, Iziduh S, Usoroh E, Ali T, Ibeziako V, Oladimeji O, Odo M. Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons. World J Virology 2015; 4(2): 105-112 [PMID: 25964875 DOI: 10.5501/wjv.v4.i2.105] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
77 Hall C, Sukijthamapan P, dos Santos R, Nourse C, Murphy D, Gibbons M, Francis JR. Challenges to delivery of isoniazid preventive therapy in a cohort of children exposed to tuberculosis in Timor-Leste. Trop Med Int Health 2015;20:730-6. [PMID: 25682846 DOI: 10.1111/tmi.12479] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
78 Sharifi Mood B, Metanat M, Khalili M. Active Pulmonary Tuberculosis Despite Isoniazid Chemoprophylaxis in Children Who Were Exposed to Smear Positive Pulmonary Tuberculosis: Case Series. Int J Infect 2015;2. [DOI: 10.17795/iji-21985] [Reference Citation Analysis]
79 Sloot R, Schim van der Loeff MF, Kouw PM, Borgdorff MW. Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. Am J Respir Crit Care Med 2014;190:1044-52. [PMID: 25265362 DOI: 10.1164/rccm.201406-1159OC] [Cited by in Crossref: 124] [Cited by in F6Publishing: 132] [Article Influence: 15.5] [Reference Citation Analysis]
80 Jeena PM. Editorial commentary: Contact tracing in children exposed to an index case of tuberculosis: the need, the challenge, and the impact. Clin Infect Dis 2015;60:19-20. [PMID: 25270647 DOI: 10.1093/cid/ciu754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]